Spirits brands owner Distil (LON: DIS) has secured a US distributor to relaunch Blavod Black Vodka in the US. AIKO Importers has a network of 185 distribution partners in the US, Canada and Puerto Rico and relationships with retailers. Blavod Black Vodka is the company’s original brand and shipments should start in June. Distil is assuming that tariffs remain in place and that they are manageable. The share price rebounded 32.1% to 0.0925p.
Cancer vaccines developer Scancell Holdings (LON: SCLP) is partnering with the NHS Cancer Vaccine Launch Pad to fast-track NHS patients into the fourth cohort of the phase 2 clinical SCOPE study. This is to evaluate the iSCIB1+, targeted off the shelf Immunobody second generation DNA cancer vaccine in patients with advanced unresectable melanoma. The share price increased 21.2% to 10p.
Metals One (LON: MET1) has appointed Fairfax Partners Inc to enhance international investor relations. Investors outside of the UK are becoming more interested in the company because of its focus on critical metals in Europe. The share price improved 11.5% to 29p.
Fire suppression technology developer Zenova Group (LON: ZED) has formed a joint venture to establish a manufacturing facility in Albania. This could be up and running in May and could generate €2m in the subsequent 12 months. The share price rose 13.2% to 0.215p.
Anglo Asian Mining (LON: AAZ) produced 8,085 gold equivalent ounces in the first quarter of 2025. This is the first full quarter since the environmental shut down. There was a net cash inflow of $1m and net debt fell to $13.8m. Full production will begin at the Gilar mine in May. The share price is 7.92% higher at 129.5p.
FALLERS
Pantheon Resources (LON: PANR) says there were no signs of hydrocarbons at the first test zone of the Megrez well in Alaska. Pantheon Resources has tried to put a positive spin on the results by suggesting that higher hydrocarbon saturations and mobile oil in the shallower test zones. There will be a pause before the second test. The share price slumped 44.9% to 28.775p.
Software company Cerillion (LON: CER) says profit will be second half weighted, and the interim revenues will be lower. There were lower licence sales in the period with renewals and expansions due in the second half. There could be a major extension to a contract with an existing telecoms client. Full year revenues are still expected to rise from £43.8m to £47.7m, although pre-tax profit is likely to be flat. Net cash was £31m at the end of March 2025. The share price dipped 1.92% to 1275p.